To determine whether Pneumocystis carinii is associated with clinical illne
ss in the competent host, 107 normal, healthy infants were enrolled in a 2-
year prospective cohort study in Chile. P. carinii was identified by specif
ic stains and nested-deoxyribonucleic acid (DNA) amplification of the large
subunit mitochondrial ribosomal ribonucleic acid gene of P. carinii f. sp.
hominis, and seroconversion was assessed by enzyme-linked immunosorbent as
say of serum samples drawn every 2 months. P. carinii DNA was identified in
nasopharyngeal aspirates obtained during episodes of mild respiratory infe
ction in 24 (32%) of 74 infants from whom specimens were available for test
ing. Three (12.5%) of those 24 infants versus 0 of 50 infants who tested ne
gative for P. carinii had apnea episodes. Seroconversion developed in 67 (8
5%) of 79 infants who remained in the study by 20 months of age and occurre
d in the absence of any symptoms of disease in 14 (20.8%). The study indica
tes that P. carinii DNA can be frequently detected in healthy infants, and
it raises the hypothesis that they may be an infectious reservoir of P. car
inii in the community. Further investigation is needed to identify whether
P. carinii causes overt respiratory disease in infants.